Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Navid Nezafat

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Biomaterials Advances|February 18, 2024
A versatile theranostic magnetic polydopamine iron oxide NIR laser-responsive nanosystem containing doxorubicin for chemo-photothermal therapy of melanomaMahvash Dehghankhold, Fatemeh Ahmadi, Navid Nezafat, et al.
Journal of Biomolecular Structure & Dynamics|January 13, 2019
Vaccinomics approach for developing multi-epitope peptide pneumococcal vaccineHesam Dorosti, Mahboobeh Eslami, Manica Negahdaripour, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|December 19, 2017
Structural vaccinology considerations for in silico designing of a multi-epitope vaccineManica Negahdaripour, Navid Nezafat, Mahboobeh Eslami, et al.
Plos Neglected Tropical Diseases|July 15, 2024
Design and expression of a chimeric recombinant antigen (SsIR-Ss1a) for the serodiagnosis of human strongyloidiasis: Evaluation of performance, sensitivity, and specificityMostafa Omidian, Zohreh Mostafavi-Pour, Marzieh Asadi, et al.
Plos Neglected Tropical Diseases|January 29, 2025
Correction: Design and expression of a chimeric recombinant antigen (SsIR-Ss1a) for the serodiagnosis of human strongyloidiasis: Evaluation of performance, sensitivity, and specificityMostafa Omidian, Zohreh Mostafavi-Pour, Marzieh Asadi, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|August 7, 2017
A novel HPV prophylactic peptide vaccine, designed by immunoinformatics and structural vaccinology approachesManica Negahdaripour, Mahboobeh Eslami, Navid Nezafat, et al.
Recent Patents on Biotechnology|May 31, 2024
Designing a Secretory form of RTX-A as an Anticancer Toxin: An <i>In Silico</i> ApproachMortaza Taheri-Anganeh, Navid Nezafat, Saba Gharibi, et al.
Journal of Molecular Modeling|November 18, 2022
Designing a humanized immunotoxin based on DELTA-stichotoxin-Hmg2a toxin: an in silico studyZeinab Ghesmati, Samira Mokhtari, Maliheh Parvanak, et al.
Scientific Reports|December 9, 2021
Hotspots for mutations in the SARS-CoV-2 spike glycoprotein: a correspondence analysisMohammad Reza Rahbar, Abolfazl Jahangiri, Saeed Khalili, et al.
Current Pharmaceutical Biotechnology|November 16, 2019
Production and Preliminary In Vivo Evaluations of a Novel in silico-designed L2-based Potential HPV VaccineManica Negahdaripour, Navid Nezafat, Reza Heidari, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Biomaterials Advances|February 18, 2024
A versatile theranostic magnetic polydopamine iron oxide NIR laser-responsive nanosystem containing doxorubicin for chemo-photothermal therapy of melanomaMahvash Dehghankhold, Fatemeh Ahmadi, Navid Nezafat, et al.
Journal of Biomolecular Structure & Dynamics|January 13, 2019
Vaccinomics approach for developing multi-epitope peptide pneumococcal vaccineHesam Dorosti, Mahboobeh Eslami, Manica Negahdaripour, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|December 19, 2017
Structural vaccinology considerations for in silico designing of a multi-epitope vaccineManica Negahdaripour, Navid Nezafat, Mahboobeh Eslami, et al.
Plos Neglected Tropical Diseases|July 15, 2024
Design and expression of a chimeric recombinant antigen (SsIR-Ss1a) for the serodiagnosis of human strongyloidiasis: Evaluation of performance, sensitivity, and specificityMostafa Omidian, Zohreh Mostafavi-Pour, Marzieh Asadi, et al.
Plos Neglected Tropical Diseases|January 29, 2025
Correction: Design and expression of a chimeric recombinant antigen (SsIR-Ss1a) for the serodiagnosis of human strongyloidiasis: Evaluation of performance, sensitivity, and specificityMostafa Omidian, Zohreh Mostafavi-Pour, Marzieh Asadi, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|August 7, 2017
A novel HPV prophylactic peptide vaccine, designed by immunoinformatics and structural vaccinology approachesManica Negahdaripour, Mahboobeh Eslami, Navid Nezafat, et al.
Recent Patents on Biotechnology|May 31, 2024
Designing a Secretory form of RTX-A as an Anticancer Toxin: An <i>In Silico</i> ApproachMortaza Taheri-Anganeh, Navid Nezafat, Saba Gharibi, et al.
Journal of Molecular Modeling|November 18, 2022
Designing a humanized immunotoxin based on DELTA-stichotoxin-Hmg2a toxin: an in silico studyZeinab Ghesmati, Samira Mokhtari, Maliheh Parvanak, et al.
Scientific Reports|December 9, 2021
Hotspots for mutations in the SARS-CoV-2 spike glycoprotein: a correspondence analysisMohammad Reza Rahbar, Abolfazl Jahangiri, Saeed Khalili, et al.
Current Pharmaceutical Biotechnology|November 16, 2019
Production and Preliminary In Vivo Evaluations of a Novel in silico-designed L2-based Potential HPV VaccineManica Negahdaripour, Navid Nezafat, Reza Heidari, et al.
Pageof 10